What happens when a patient is under the ODB plan and a drug is not of benefit?

The correct choice is that the Ontario Drug Benefit (ODB) plan does not reimburse for that specific drug brand when the drug is determined to not be of benefit. The ODB is designed to provide coverage for medications deemed clinically effective and necessary for the treatment of specific conditions. When a medication is assessed and found to not meet these criteria, the reimbursement under the ODB will not apply to that drug brand.

This means that while the patient may still have access to the medication through other means, they will not receive reimbursement for it under the ODB plan, which can impact their financial responsibility for that drug. Therefore, patients may need to explore alternatives that are covered by ODB or discuss with their healthcare provider about different therapeutic options that would be reimbursed.